Aster DM Healthcare Ltd Share Price

Overview

Aster DM Healthcare Ltd share price is currently ₹743.72, up by ₹1.17 (0.16%) from its previous closing price of ₹742.55. The share price has declined -7.2% over the past month and gained 23.21% over the past year. The stock's 52-week low and high are ₹508.19 and ₹880.53, respectively. Aster DM Healthcare Ltd has a market capitalisation of ₹ 66,380.00 Cr. The share price was last updated on 28 Aug 2026, 03:51 PM IST.

Aster DM Healthcare Ltd
Aster DM Healthcare Ltd
ASTERDM
 0.00
 1.17
0.16%
Healthcare
 0.00(%)1D

Updated: 28 Aug 2026, 03:51:16 pm IST

Market Data

Open Price

 749.94

Prev. Close

 742.55
 739.35

Day Low

 760.44

Day High

 508.19

52 Week Low

 880.53

52 Week High

HealthcareHospital & Healthcare Services
CategoryLarge Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

120.93

Sector PE

42.03

PB Ratio

12.20

Sector PB

5.80

EPS

6.15

Dividend Yield

25.37

Today's Volume

1.764 M

5 Day Avg. Volume

3.219 M

PEG Ratio

0.03

Market Cap.

₹ 66,380.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

ActionsEx-DateRecord-Date
DividendsInterim Dividend of 30% at ₹3/Share
02-Apr-202603-Apr-2026
DividendsFinal Dividend of 10% at ₹1/Share
28-Aug-202528-Aug-2025
DividendsInterim Dividend of 40% at ₹4/Share
10-Feb-202510-Feb-2025

Mutual Fund Ownership

Mutual Fund Holder
Jun 26
Shares held
Jul 26
Shares held
HDFC Small Cap Fund - Regular Plan - Growth1.97 Cr
1.97 Cr
no change
Kotak Small Cap Fund - Growth1.13 Cr
1.13 Cr
(0.09%)
Quant Small Cap Fund - Growth1.13 Cr
1.13 Cr
no change
Kotak Midcap Fund - Regular Plan - Growth85.19 Lac
93.03 Lac
(9.21%)
SBI Contra Fund - Regular Plan - IDCW92.00 Lac
92.00 Lac
no change

About Aster DM Healthcare Ltd 👋

Aster DM Quality Care Limited, formerly Aster DM Healthcare Limited, is an India-based healthcare service provider. The Company is operating in India with a presence across primary, secondary, tertiary, and quaternary healthcare through approximately 19 hospitals with 5,159 beds, 10 clinics, 203 pharmacies (Operated by Alfaone Retail Pharmacies Private Limited under brand license from Aster), and 262 labs and patient experience centers across five states in India. Its center of excellence includes Cardiac Sciences, Neurosciences, Gastro Sciences, Orthopaedics, Multi-Organ Transplant. Its pharmacy offers operating 203 pharmacies across southern India, delivering quality pharmaceutical, nutritional, infant care, lifestyle, and wellness products to communities and expanding healthcare access. Its labs deliver diagnostic services covering Biochemistry, Microbiology, Hematology, Clinical Pathology, Histopathology and Cytogenetics.

Expert Opinions

Insights from SEBI-registered analysts · updated live

Explore all →
Chahat Aggrawal

Chahat Aggrawal

26 Aug • 9:22 PM · SEBI-Registered Analyst

Aster DM Quality Care Promoter Pledges 2.29% Stake

🏥

ASTERDM
Quality Care promoter Union (Mauritius) Holdings Limited has disclosed an indirect encumbrance over a 2.29% stake in the company. The encumbered shares have been provided as security for US$210 million in loans, with the borrowings intended for general corporate purposes. The development increases the level of promoter-linked shares under encumbrance and will be closely monitored by investors as part of the company's overall shareholding structure. While the financing provides access to funds for corporate requirements, changes in promoter pledge or encumbrance levels are an important factor for shareholders to track. Further disclosures could provide additional clarity on the financing arrangement, security structure and any future changes in the promoter's encumbered holding.

See More
AALGO BREATHS I SEBI RA

AALGO BREATHS I SEBI RA

25 Aug • 11:29 PM · SEBI-Registered Analyst

Aster DM Healthcare Ltd – Support Zone Setup

ASTERDM
The stock is currently trading near an important support zone following a recent correction. Price action suggests that the stock is attempting to stabilize around the ₹750–₹731 range, where buyers may look to defend the downside. Although short-term momentum remains relatively weak, the easing of selling pressure indicates that a potential recovery setup could develop if the support zone continues to hold. 🔎 Technical View: • The stock is trading close to the key ₹750–₹731 support zone. • Recent selling pressure appears to have eased, indicating some stabilization at lower levels. • Short-term momentum remains weak, so confirmation of strength is important. • A sustained hold above the support zone could provide a base for a potential recovery. • A decisive move above the immediate resistance area may strengthen the bullish setup and attract fresh buying interest. 🔑 Key Levels: • Support: ₹750–₹731 • Immediate Resistance: ₹768–₹786 • A sustained move above ₹786 could indicate improving short-term strength. 🚀 Potential Targets: • Target 1: ₹803 • Target 2: ₹821 • Target 3: ₹843+ 📉 Risk: A decisive breakdown below ₹731 could weaken the current recovery setup and may lead to further selling pressure. Therefore, ₹731 remains an important level to monitor from a risk-management perspective. 📈 View: The stock is currently at an important technical juncture. If the ₹750–₹731 support zone continues to hold and the price manages to sustain above ₹786, a gradual recovery towards ₹803, ₹821 and potentially ₹843+ could be possible. However, traders should monitor price action closely and look for confirmation rather than relying solely on the support zone. ⚠️ For educational purposes only. Not a buy/sell recommendation. — AALGO BREATHS 📊

See More
THREETREND RESEARCH

THREETREND RESEARCH

20 Aug • 7:49 AM · SEBI-Registered Analyst

AsterDM

ASTERDM
The price is moving in an uptrend by forming higher lows, with the rising trendline acting as an important support zone. Each correction has found buying interest near the trendline, indicating that buyers are defending this level. As long as the higher-low structure and trendline support remain intact, the bullish trend can continue; a decisive breakdown below the trendline may signal weakness.

See More
Sohrab Shaikh (SEBI RA)

Sohrab Shaikh (SEBI RA)

19 Aug • 10:34 PM · SEBI-Registered Analyst

High delivery stock

Symbol Delivered Qty ASTERDM 62324493 APOLLOTYRE 1551426 RAILTEL 1004625 ATGL 1378460 HSCL 7592497 AIIL 443706 JUBLPHARMA 712444 GLAXO 438502 SWIGGY 8661820 PFIZER 111827 SOBHA 109386 IGL 1962541 PFOCUS 884325 AADHARHFC 670510

ASTERDM

See More
Umang Bhutada

Umang Bhutada

19 Aug • 4:20 PM · SEBI-Registered Analyst

Aster DM Quality Care: Huge Volume Spike With Price Weakness

ASTERDM
Aster DM Quality Care Ltd (ASTERDM) witnessed a significant surge in trading activity on Wednesday, with NSE volumes reaching **718.26 lakh shares by 2:14 PM**. This represented a **71.76x increase** compared with the stock's two-week average daily volume of 10.01 lakh shares. Despite the massive volume expansion, the stock was trading around **₹805**, down 1.59% at the time of the report. ### What Makes This Interesting? * **Volume:** 718.26 lakh shares * **Two-week average:** 10.01 lakh shares * **Volume spike:** 71.76x * **Price:** ₹805 * **Price movement:** -1.59% A sharp increase in volume accompanied by weak price action is an important development to monitor because it can indicate significant activity around the stock. ### Technical View The focus now should be on whether the stock can **stabilise after the volume spike** or whether increased participation continues to accompany selling pressure. Price-volume behaviour over the next few sessions will provide better confirmation of the underlying trend. ### Alpha Insight **Don't look at volume in isolation.** The relationship between **price + volume + key technical levels** provides a much clearer picture of market behaviour. *For educational and informational purposes only. Not investment advice.* **UMANG RAJESH BHUTADA** SEBI Registered Research Analyst Registration No. **INH000023001** SEBI registration does not guarantee returns or profits.

See More
Akhilesh Jat SEBI RA

Akhilesh Jat SEBI RA

19 Aug • 10:25 AM · SEBI-Registered Analyst

Aster DM Quality Care Recovers After 6.34% Morning Fall as Block Deal Report Triggers Volatility

Aster DM Quality Care Ltd. (

ASTERDM
) witnessed sharp volatility on August 19 after reports emerged that Centella Mauritius Holdings, a TPG-affiliated investor, may sell a 7.2% stake through a block deal at a floor price of ₹766.10 per share. The stock fell as much as 6.34% in morning trade following the news. However, the selling pressure eased quickly, and by 10:15 am, the stock had recovered and moved into positive territory. Recent Performance • Hit a fresh all-time high of ₹891.30 on August 10, 2026 • Closed lower for seven consecutive trading sessions thereafter • Declined nearly 14% from the all-time high to today’s intraday low • Still up 34.83% YTD in calendar year 2026 Why Is the Stock in Focus? Aster DM Quality Care’s sharp morning decline reflects immediate market sensitivity to the reported block deal involving Centella Mauritius Holdings. The proposed sale of a 7.2% stake at a ₹766.10 floor price can create near-term supply pressure. However, the subsequent recovery into positive territory suggests that the selling pressure was absorbed relatively quickly, indicating that investors were not uniformly bearish despite the stake-sale overhang. 📌 Disclaimer: This content is for information only and not investment advice. Investments in securities market are subject to market risks. Read all the related documents carefully before investing. Please consult a SEBI-registered advisor before making any investment decisions.

See More

News & Events

Frequently Asked Questions

What is the share price of Aster DM Healthcare Ltd?

What is the market cap of Aster DM Healthcare Ltd?

Should I buy Aster DM Healthcare Ltd stock now?

What is the 52 week high and low of Aster DM Healthcare Ltd?

Is the Aster DM Healthcare Ltd stock good to buy?

Is Aster DM Healthcare Ltd a good buy for the long term?

Is Aster DM Healthcare Ltd overvalued or undervalued?

What is the PE and PB ratio of Aster DM Healthcare Ltd?

Start Now